THALLOUS CHLORIDE TI-201 INJECTION DIN 02328925
Status: Dormant
Holder: CURIUM CANADA INC
Health Canada record
| Active ingredient(s) | THALLIUM CHLORIDE(TI 201) 37 MBq |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | SCHEDULE C |
|---|
| Class | Radiopharmaceutical |
|---|
| ATC | V09GX01 THALLIUM 201 TL CHLORIDE |
|---|
| Original market date | 09-Dec-2019 |
|---|
| Current status date | 10-Oct-2023 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Curium Canada Inc. — licence 3-002566, currently licensed, last inspection rating C (2026-07-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing THALLIUM CHLORIDE(TI 201)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02327945 | THALLIUM | LANTHEUS MI CANADA INC | Solution | THALLIUM CHLORIDE(TI 201) 2 MCI | Cancelled Post Market |
| 02327961 | THALLIUM | LANTHEUS MI CANADA INC | Solution | THALLIUM CHLORIDE(TI 201) 1 MCI | Cancelled Pre Market |
| 02329824 | THALLIUM, THALLOUS CHLORIDE TI201 | BRISTOL-MYERS SQUIBB CANADA | Liquid | THALLIUM CHLORIDE(TI 201) 1 UNIT | Cancelled Pre Market |
| 02485915 | THALLOUS CHLORIDE TI 201 INJECTION | GE HEALTHCARE CANADA INC | Solution | THALLIUM CHLORIDE(TI 201) 37 MBq | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 22095 | 2019-04-26 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
Request a quote for THALLOUS CHLORIDE TI-201 INJECTION
How to read a Canadian DIN record